Live
- Sunny Leone's Name Used in Fraud Under Chhattisgarh’s Mahtari Vandan Yojana
- Gold Business Fraud Uncovered in Atmakur, Wanaparthy
- Rachakonda Police Seize Rs.88 Crore Worth Drugs, Arrest 521 Accused
- Sriram Krishnan Appointed Senior Policy Advisor for AI at the White House
- Cyclone alert at seven ports in Tamil Nadu; rain, strong winds expected
- Uttarakhand CM to attend MP govt's 'Jan Kalyan Parv' in Sagar today
- Sri Jagdamba Pearls Expands Presence with the launch of its Second Store in Bengaluru at Lulu Mall
- Congress remembers Dalits only in bad times: Mayawati taunts Rahul Gandhi on Parbhani visit
- Have time for jailed leaders but none for achievers: BJP slams Delhi govt over chess champion’s pain
- Alliance University holds 13th Convocation, 1145 students receive degrees
Glenmark gets nod for blood pressure drugs
Highlights
Glenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (US FDA) for Bisoprolol Fumarate and Hydrochlorothiazide which are used to treat blood pressure.
Hyderabad: Glenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (US FDA) for Bisoprolol Fumarate and Hydrochlorothiazide which are used to treat blood pressure.
The tablets are of strength 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg. These are generic versions of Ziac tablets, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg, of Teva Branded Pharmaceutical Products R&D. According to IQVIATM sales data for the 12 month period ending November 2021, these drugs achieved annual sales of approximately $30.3 million.
Glenmark's current portfolio consists of 172 products authorized for distribution in the US marketplace and 46 ANDA's pending approval with the US FDA.
Next Story
ADVERTISEMENT
